Positive Processes and Transition to Health (PATH) (NCT06093906)
Treatment of Stress-Related Psychopathology: Targeting Maladaptive and Adaptive Event Processing
🩺 Plain-English Summary (8th-Grade Level)
The R33 will be a randomized controlled trial to replicate changes in the targets (unproductive processing, avoidance, reward deficits) from the R61 phase in a larger sample of 135 participants who have experienced a destabilizing life event involving profound loss or threat, report persistent stressor-related symptoms of PTSD and/or depression, and are elevated on symptoms related to 2 of the 3 therapeutic targets. Additionally, this study will examine Positive Processes and Transition to Health (PATH)'s impact on stressor-related psychopathology in comparison to Progressive Muscle Relaxation (PMR). In the R33 phase, the investigators will examine changes in target mechanisms predicting improvements in PTSD and depressive symptoms, as well as feasibility and acceptability. Patients will receive 6 sessions of PATH or PMR (with 2 boosters, if partial responders). Primary targets will be assessed at pre-treatment, week 3, post-treatment, and at 1- and 3-month follow-up; secondary targets at pre-treatment, weekly during treatment, post-treatment, and at 1- and 3-month follow-ups.
Who can join: Review the eligibility criteria below.
Location: University of Delaware — Newark, Delaware
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
- Positive Processes and Transition to Health (BEHAVIORAL)
- Progressive Muscle Relaxation (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- University of Delaware — Newark, Delaware
- Case Western Reserve University — Cleveland, Ohio
- University of Washington — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (216) 368-0338
Email: ptsdlab@case.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Posttraumatic Stress Disorder
- Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests — Seattle, Washington
- A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD — Birmingham, Alabama
- Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes — Grand Rapids, Michigan
- Using Data Science To Center Patient Perspectives in Mechanism Discovery — Malden, Massachusetts
- Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD — Palo Alto, California
- Enhancing Week-long Psychological Treatment for PTSD With Ketamine — New Haven, Connecticut
Explore by condition: All Posttraumatic Stress Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.